GlassScriptPhysician profile
Andrew B Baker
NPI 1891157343
$7,657.11
in general payments reported to CMS, 2019-2025
16 companies · $1,959 in 2025
The $1,959 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,560 · 2022: $990 · 2023: $588 · 2024: $559 · 2025: $1,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,430 · Travel and Lodging: $558 · Consulting Fee: $60.00 · Education: $58.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,429.78 |
| Travel and Lodging | $558.49 |
| Consulting Fee | $60.00 |
| Education | $58.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,628.02 | 2021 | |
| Aerin Medical INC. | $1,337.60 | 2023-2025 | |
| Medical Device Business Services, INC. | $1,236.43 | 2021-2022 | |
| Medtronic, INC. | $693.06 | 2023-2025 | Propel, Nuvent, Sinuva |
| Glaxosmithkline, LLC. | $540.66 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $299.06 | 2025 | Dupixent |
| Genzyme Corporation | $219.77 | 2023-2025 | |
| Stryker Corporation | $171.90 | 2021 | |
| Smith+Nephew, INC. | $166.27 | 2021 | |
| Depuy Synthes Sales INC. | $161.33 | 2021 | |
| Karl Storz Endoscopy-America | $97.59 | 2021 | |
| Inspire Medical Systems, INC. | $28.00 | 2024 | Inspire |
| Azurity Pharmaceuticals, INC. | $22.50 | 2025 | Alvesco |
| Astrazeneca Pharmaceuticals LP | $22.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.86 | 2025 | Hyqvia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $15.06 | 2023 | Trudi Nav Cable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.